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INTRODUCTION 
The rapid removal of intravenously administered 
colloidal drug carrier systems by the mononuclear 
phagocytic system (MPS) is an obstacle to the 
efficient targeting of solid tumours and 
inflammatory tissues[1,2]. Knowledge on the 
interaction between macrophages and drug 
carriers is essential in the design of more effective 
therapeutic strategies using nanobiotechnological 
devices. Macrophages may be the therapeutic 
target, for the treatment of macrophage-associated 
pathologies or vaccination purposes, given their 
activity as antigen-presenting cells[3,4]. Otherwise, 
when other targets are envisaged, phagocytic 
activity should ideally be avoided, providing the 
drug carrier time enough to reach the target.  
In this work, the interaction between dextrin 
nanoparticles (with two populations: 25 and 150 
nm) - recently developed in our laboratory - and 
murine bone marrow-derived macrophages 
(BMDM) was evaluated (cytotoxicity and nitric 
oxide production). Fluorescein-labelled 
nanoparticles were used to assess the phagocytic 
uptake (in vitro by Confocal Laser Scanning 
Microscopy) and blood clearance after 
intravenous injection.  
MATERIALS AND METHODS 
Cytotoxicity and Nitric Oxide Production  
The cytotoxicity of the dextrin nanoparticles was 
evaluated, in vitro, using the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium 
bromide (MTT) assay. The tetrazolium salt is 
widely used to quantify cytotoxicity, by 
colorimetry, that is metabolically reduced to 
highly coloured end products, formazans[5]. The 
nitric oxide production was evaluated by 
quantifying the nitrite accumulation in cell culture 
supernatants using the Griess method[6]. 
 
Confocal observation of the macrophages 
In order to evaluate the phagocytic activity, 
macrophages were seeded on coverslips and 
stimulated with LPS (100 ng/mL) and IFN-γ (1 
ng/mL). Then, the cell culture was incubated with 
or without fluorescein-containing nanoparticles 
(1.0 or 0.1 mg/mL) for 6 h. The cover glasses 
were washed twice with PBS and cells were fixed 
with methanol absolute and labelled with DAPI 
(staining nucleous-blue).  
Blood Clearance 
A solution of fluorescein-labelled nanoparticles 
(100 µL, 0.3 mg/mL) was injected in the tail vein. 
After pre-defined periods following nanoparticles 
administration, blood was collected through tail 
cut. Blood was centrifuged (14000 rpm, 40 min, 
4ºC) and the fluorescence intensity of supernatant 
was analysed. The samples corresponding to the 
beginning of the experiment (0 h) were collected 
immediately after injection.  
RESULTS AND DISCUSSION 
The presence of nanoparticles, in the range of 
concentrations studied, does not affect cell 
viability as measured by the MTT assay (Figure 
1a). Cells treated with nanoparticles showed a 
MTT optical density similar to the control 
(untreated cells). The nanoparticles effect on the 
nitric oxide production by cultured macrophages 
was analysed (Figure 1b). Cells were incubated 
for 48 h with nanoparticles alone and the 
production of nitric oxide was not detected in the 
conditions of the assay. Moreover, as expected, 
the addition of LPS and IFN-γ to the culture 
medium induced nitric oxide production. The 
effect of combining LPS and IFN-γ with different 
nanoparticles concentration revealed that the 
release of nitric oxide was similar, irrespective of 
the presence of nanoparticles. The presence of the 
nanoparticles seems not to promote any 
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inflammatory action or elicit a reactive response 
when in contact with macrophages. 
 
Figure 1 – BMDM viability (a) with different nanoparticles 
concentrations (1.0 or 0.1 mg/mL) and nitric oxide production 
(b) using 0.5 or 0.1 mg/mL nanoparticles, after 24 (    ) or 48 h 
(  ) of incubation. For nitric oxide assay BMDM were 
stimulated with LPS (100 ng/mL) and IFN-γ (1 ng/mL). The 
error bar corresponds to the standard deviation. 
 
Figure 2 Fluorescence images of BMDM obtained by confocal 
microscopy, without nanoparticles contact (a), and with 6 h of 
incubation with fluorescein-containing nanoparticles, 0.1 
mg/mL (b) or 1.0 mg/mL (c).  
 
Confocal microscopy was used to examine the 
uptake of fluorescein-labelled nanoparticles by 
macrophages. In the control culture (Figure 2a) 
only nucleus stained with DAPI are visible. Cells 
incubated with nanoparticles show small green 
spots (Figure 2b, c), in the cytoplasm, that can be 
attributed to the fluorescein in the internalised 
nanoparticles. Fluorescent material is concentrated 
in cellular organelles, irrespective of the 
concentration used. The cell membrane is not 
visible, suggesting that the nanoparticles are not 
adsorbed on the cell surface. 
 
Figure 3 - Blood clearance profile of fluorescein-labelled 
nanoparticles. Inset shows the percentage of the initial (0 h) 
fluorescence, remaining in the bloodstream at different time. 
The error bar corresponds to the standard deviation. 
The blood clearance profile for fluorescein-
labelled nanoparticles is shown in figure 3. The 
elimination of nanoparticles from systemic 
circulation is relatively fast in the first 3 hours, 
then proceeding at lower rate. In the first period 
studied, 3 h, about 65% of the nanoparticles were 
removed from the bloodstream and in the next 2 h 
another 15% fade away. At 24 h, only 5% of the 
injected dose is circulating in the bloodstream.  
CONCLUSIONS 
In vitro studies with BMDM revealed that 
nanoparticles are non cytotoxic and do not elicit a 
reactive response when in contact with 
macrophages. Confocal observation demonstrated 
that BMDM internalize the nanoparticles. The 
blood clearance profile reveal a moderately long 
circulation time, compatible with drug delivery or 
diagnostic applications. Dextrin nanoparticles may 
be used to address phagocytic cells.  
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